Empagliflozin: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* SGLT2 inhibitor * Start at 10 mg PO daily, then titrate up * Indicated for type 2 diabetes mellitus and chronic heart failure (both HFrEF and HFpEF) Category:Medi..." |
(No difference)
|
Latest revision as of 16:22, 14 October 2021
- SGLT2 inhibitor
- Start at 10 mg PO daily, then titrate up
- Indicated for type 2 diabetes mellitus and chronic heart failure (both HFrEF and HFpEF)
